Carman Alenson
SVP, Finance and Chief Accounting Officer · Prime Medicine, Inc.
Individual
- 2025
- Feb 24, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Carman Alenson. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ARCH Venture Partners X, LLC - $10.00M in PRME purchases and sales on record
- Robert Nelsen - $10.00M in PRME purchases and sales on record
- ARCH Venture Partners XII, LLC - $10.00M in PRME purchases and sales on record
- GV 2021 GP, L.L.C. - $4.95M in PRME purchases and sales on record
- David R. Liu - $53K in PRME purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Carman Alenson?
Carman Alenson is a corporate insider, tracked as SVP, Finance and Chief Accounting Officer of Prime Medicine, Inc. (PRME). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Carman Alenson last file a Form 4?
The most recent primary Form 4 on record is dated 24 February 2026, one of 2 filings going back to 2025.